Platinum Investment Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-55,341
| Closed | -$1.63M | – | 149 |
|
|
2023
Q2 | $1.63M | Hold |
55,341
| – | – | 0.06% | 86 |
|
|
2023
Q1 | $1.28M | Hold |
55,341
| – | – | 0.04% | 95 |
|
|
2022
Q4 | $1.54M | Buy |
55,341
+4,370
| +9% | +$122K | 0.06% | 90 |
|
|
2022
Q3 | $1.56M | Hold |
50,971
| – | – | 0.07% | 85 |
|
|
2022
Q2 | $1.5M | Hold |
50,971
| – | – | 0.06% | 94 |
|
|
2022
Q1 | $1.64M | Hold |
50,971
| – | – | 0.05% | 90 |
|
|
2021
Q4 | $2.27M | Buy |
50,971
+20,180
| +66% | +$900K | 0.06% | 92 |
|
|
2021
Q3 | $1.55M | Hold |
30,791
| – | – | 0.04% | 109 |
|
|
2021
Q2 | $2.42M | Hold |
30,791
| – | – | 0.06% | 87 |
|
|
2021
Q1 | $1.76M | Hold |
30,791
| – | – | 0.04% | 93 |
|
|
2020
Q4 | $2.58M | Sell |
30,791
-40,002
| -57% | -$3.35M | 0.06% | 80 |
|
|
2020
Q3 | $2.54M | Hold |
70,793
| – | – | 0.06% | 71 |
|
|
2020
Q2 | $1.71M | Hold |
70,793
| – | – | 0.04% | 92 |
|
|
2020
Q1 | $1.24M | Buy |
+70,793
| New | +$1.24M | 0.03% | 93 |
|